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Background: This clinical study aimed to radiologically and clinically compare the effect of intra-articular injec-
tion of methylprednisolone, sodium hyaluronate or tenoxicam following arthrocentesis with that of arthrocentesis 
alone in patients with non-reducing disc displacement.
Material and Methods: A total of 44 patients radiographically diagnosed with non-reducing disc displacement of 
the temporomandibular joint (TMJ) were randomly divided into four treatment groups, as follows: Group 1, ar-
throcentesis alone; Group 2, arthrocentesis plus methylprednisolone acetate; Group 3, arthrocentesis plus sodium 
hyaluronate; Group 4, arthrocentesis plus tenoxicam. Maximum mouth opening (MMO), lateral movement, pain 
severity and tenderness of TMJ and muscles of mastication on palpation were measured before treatment and at 1 
week and 1, 3 and 6 months after treatment. Disc position, presence or absence of disc reduction, level of effusion, 
joint movement and joint space were also evaluated using magnetic resonance imaging (MRI) before treatment 
and 6 months after treatment. 
Results: No significant differences in treatment success were found among the four groups. MRI findings did not 
vary significantly among the groups, but pre- and post-operative MRI findings varied significantly within all four 
groups (p<0.001).
Conclusions: According to the data from this study, it may be concluded that either arthrocentesis alone or ar-
throcentesis with methylprednisolone acetate or sodium hyaluronate or tenoxicam intra-articular injections are 
similarly effective and promising methods in the treatment of TMJ with non-reducing disc displacement.  
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Introduction
Arthrocentesis, i.e. lavage of the superior joint space, was 
first described by Nitzan in 1991 (1). The main indications 
for arthrocentesis are acute or chronic restricted move-
ment deriving from non-reducing disc displacement and 
hypomobility associated with limited condyle translation 
in the superior joint space (2). Arthrocentesis may also 
be indicated for patients with osteoarthritis and rheuma-
toid arthritis. Arthrocentesis reduces pain by eliminating 
inflammatory mediators (3), increases condyle mobility 
by eliminating intra-articular negative pressure and ad-
hesions (1,3), and increases the mobility of a joint whose 
movement has been constricted as a result of anterior dis-
placement (3). Arthrocentesis is a simple procedure that 
can be repeated if necessary, requires no special equip-
ment, and has low complication rates, making it a popu-
lar and widely used technique in the treatment of internal 
derangements of the temporomandibular joint (TMJ) (3). 
Intra-articular drug injections can be applied alone or fol-
lowing arthrocentesis or arthroscopic surgery; however, 
the effectiveness of intra-articular drug injections follow-
ing arthrocentesis is still controversial (4). Previous stud-
ies have looked at the intra-articular application of various 
materials, including glucocorticosteroids, sodium hyaluro-
nate (SH), tenoxicam, morphine and bupivacaine (1,5-8).
Some authors have reported intra-articular corticoste-
roid injections to reduce pain and improve function (8). 
SH, which has a high molecular weight and high viscos-
ity, has also been shown to reduce friction and pain and 
improve joint mobility by restoring soft-tissue lubrica-
tion; to play role in anti-inflammation and buffering, and 
to repair articular cartilage nutrition (9). The decrease 
in viscoelasticity and molecular weight of hyaluronate 
decrease in joints exposed to degenerative changes, 
thereby increasingly disposing them to cartilage injury. 
It has been suggested that exogenous administration of 
hyaluronate stimulates hyaluronate production by syn-
oviocytes inside the joint, reducing friction and thus 
protecting articular structures (10). It has also been sug-
gested that the biochemical structure of the joint can be 
restored to normal by replacing low-molecular-weight 
hyaluronate in the inflamed joint with high-molecular 
weight-hyaluronate applied exogenously (9).
A derivative of oxicam that falls within the enolic-
acid group of non-steroidal anti-inflammatory drugs 
(NSAID), tenoxicam has exhibited both anti-inflamma-
tory and analgesic properties. Intra-articular applica-
tion has been found to be more effective than oral and 
intravenous application in terms of analgesia (11); how-
ever, very few studies have investigated administration 
of tenoxicam into the TMJ (6,7).
Given the lack of consensus on drug use after arthrocente-
sis, additional clinical studies are required. To the best of 
our knowledge, no previous study in the English-language 
literature has compared the effectiveness of SH, dexa-
methasone and tenoxicam in the treatment of non-reduc-
ing disc displacement of the TMJ. Therefore, this study 
radiologically and clinically compared the effects of SH, 
dexamethasone and tenoxicam injected intra-articularly 
following arthrocentesis with the effects of arthrocentesis 
alone in patients with non-reducing disc displacement.
Material and Methods
- Patients
This prospective, randomized, single-blinded study 
was conducted at the Atatürk University Faculty of 
Dentistry’s Department of Oral and Maxillofacial Sur-
gery between May 2011 and April 2013. The study 
was conducted in line with the principles of the 1975 
Helsinki Declaration for biomedical research involv-
ing human subjects, as revised in 2004, and was ap-
proved by the Atatürk University Human Research Eth-
ics Committee of Faculty of Dentistry under protocol 
2011/008 and Atatürk University Health Sciences Insti-
tutional Review Board for Human Studies under pro-
tocol 2012/2012.2.12. Patients were informed about the 
surgery, postoperative recommendations and possible 
complications before the procedure, and all participants 
gave their written consent. 
The patients who were referred to our clinic with com-
plaints of TMJ pain, TMJ noises, and limitation of mouth 
opening were examined clinically and with magnetic reso-
nance images. Inclusion criteria were: Increased TMJ pain 
on chewing or during maximal mouth opening; TMJ pain 
of at least 3 on a 0–10 visual analogue scale (VAS) (rated 
from 0=no pain to 10=worst pain imaginable using a vi-
sual analogue scale); a history of joint clicking and limited 
mouth opening (<35 mm), together with a deviation to the 
affected side and an increase of up to 3 mm in mouth open-
ing with assistance; limited lateral and protrusive move-
ment, with deviation to the affected side; symptoms dura-
tion of at least 2 months; a primary TMJ pain complaint 
diagnosed as arthralgia and disc displacement without 
reduction according to the Research Diagnostic Criteria 
(RDC)/TMD (12). In all patients, the presence of non-
reducing disc displacement was confirmed by magnetic 
resonance imaging (MRI). No patient had previously been 
treated for disorders of the TMJ. Exclusion criteria were 
as follows: Pregnancy and lactation; presence of a medical 
condition or drug use that might affect the surgical pro-
cedure or post-surgical healing; previous exposure of the 
TMJ to direct trauma or fracture of facial bones, or previ-
ous history of TMJ surgery; signs or symptoms of myal-
gia; condylar hypoplasia/hyperplasia or tumor, presence of 
facial growth disorder or systemic inflammatory joint dis-
ease, or history of severe degenerative joint disease (MRI 
signs of deformed condylar contour or osteopenia together 
with osteophyte or roughness of the condylar surface and 
bony changes in the glenoid fossa) or bony/fibrous adhe-
sion; or contraindication at MRI. Patient psychological 
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status was also evaluated at the start of treatment, and pa-
tients with depression or somatization according to Dwor-
kin and Le Resche (13) were also excluded.
52 individuals were initially selected but of these, 8 
were excluded according to the exclusion criteria. Sam-
ple selection was discontinued at 44 patients (38 wo-
men, 6 men). Patient demographics, medical and dental 
anamneses and TMJ examinations were completed dur-
ing the initial presentation. Clinical examinations were 
conducted, and all patient symptoms (including initial 
symptoms and symptom durations), maximum mouth 
opening (MMO) and protrusive and lateral movement 
of the mandible, degree of pain on bimanual palpation of 
the muscles of mastication and TMJ region (rated from 
0=no pain to 10=worst pain imaginable using a VAS) 
and tooth grinding/clenching habits were recorded. 
- Radiological Examination
Clinical diagnosis was confirmed through MRI ex-
aminations. MRIs were taken with the mouth open and 
closed. Disc position, presence or absence of disc reduc-
tion, amount of effusion, range of motion and superior 
joint space width were recorded. Normal disc position 
was defined based on the location of the posterior band 
of the disc at the superior position relative to the con-
dyle. Effusion levels were classified according to Lar-
heim et al. (14) (0: no effusion; 1: effusion in the form 
of a dot or line along the articular surfaces, 2: moderate 
effusion, 3: severe effusion). A diagnosis of an internal 
derangement classifiable as non-reducing disc displace-
ment was made based on disc displacement with the 
mouth closed and no interposition of the disc between 
the condyle and articular eminence with the mouth open 
(15). Pre- and post-treatment MRIs were independently 
evaluated by a radiologist blinded to the clinical diagno-
sis and therapeutic protocol.
- Arthrocentesis 
All surgical procedures were performed by the same 
surgeon (G.Y.Y.). The patient was seated at a 45° angle 
on a dental chair with the head turned towards the unaf-
fected side. The target site was prepared, and the exter-
nal auditory meatus was blocked with damp cotton. The 
ear and periaruricular region were wiped with antisep-
tic solution, and areas outside the procedure site were 
covered with a sterile covering. Local anesthesia (2 ml 
Ultracain® DS Forte 40 mg/ml articaine HCI, 1.2 µg/ml 
epinephrine, Sanofi-Aventis İlaçları, Istanbul, Turkey) 
was administered to block the auriculotemporal nerve, 
and arthrocentesis was performed according to the 
technique described by Nitzan et al. (1). This procedure 
was performed for 15-20 min using 200 cc of Ringer’s 
lactate under adequate pressure in order to eliminate 
catabolytes present in the synovial fluid. Patients were 
instructed to continuously open and close their mouths 
during the procedure in order to restore MMO. Next, 
one of the needles was removed and, depending on the 
study group concerned, either methylprednisolone ac-
etate, SH, or tenoxicam was injected using the remain-
ing needle. (In the case of the control group, no drug 
was administered). Once the procedures were finished, 
the mandible was gently manipulated along the vertical, 
protrusive and lateral planes in order to facilitate adhe-
sion lysis and free up the disc still further. No complica-
tions were observed during or after the procedures.
In order to prevent any relapse or joint deterioration due 
to bruxism (16), all patients were provided with stabili-
zation splints, which were prepared according to Oke-
son (17) and which were used only at night for 6 months 
following arthrocentesis. Patients were also instructed 
to perform active and passive mouth-opening exercises 
and follow a soft diet for one week following treatment 
procedures. Follow-up appointments were scheduled 
for 1 week and 1, 3 and 6 months postoperatively. At 
each follow-up session, occlusal contacts were moni-
tored, and adjustments were made as necessary.
- Treatment groups 
Patients were randomly assigned into one of four treat-
ment groups: Arthrocentesis (Group I); Arthrocentesis 
+ intra-articular SH (Hyalgan®, Bilim İlaç, Istanbul, 
Turkey) injection (Group II); Arthrocentesis + intra-ar-
ticular methylprednisolone acetate (Depo-medrol, Pfizer 
İlaçları, Istanbul, Turkey) injection (Group III); and Ar-
throcentesis + tenoxicam (Oksamen L, Mustafa Nevzat 
İlaç Sanayi, Istanbul, Turkey) injection (Group IV).
- Postoperative evaluation 
All patients were evaluated by a surgeon blinded to pa-
tient treatment, immediately before arthrocentesis and 
at 1 week and 1, 3 and 6 months postoperatively, and 
MMO, VAS pain scores and muscles of mastication and 
joint palpation values were recorded.
MRIs were obtained from all patients at 6 months post-
treatment and used to assess disc position, disc reduc-
tion, effusion level, joint range of motion and superior 
joint space width.
Arthrocentesis treatment success was evaluated at 6 
months according to American Association of Oral and 
Maxillofacial Surgeons criteria (18), as follows: MMO >35 
mm; VAS<2 (little or no pain); lateral movement >6 mm. 
- Statistical Analysis
Statistical analysis was performed using SAS (Statistical 
Analysis System Version 13.0 2002, Cary, NC) software. 
We assessed the assumption of sampling distribution 
such as normality (controlled with Kolmogorov Smirnov 
test) before statistical analysis and the hypothesis for nor-
mality was met. Descriptive data (means and standard 
deviations) were calculated, and one-Way ANOVA was 
used to compare numerical data among groups, while 
chi-square tests were used to compare qualitative data 
among groups. McNemar test was utilized to compare 
pre and post-treatment 6th monthly MRI data. Results 
were analyzed at a significance level of p<0.05.
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Results
- Clinical findings 
No significant complications were reported. No statis-
tically significant differences in mean age or gender 
distribution were identified among groups (p˃0.05). Al-
though there were more women than men in all groups, 
the differences were not statistically significant.
No statistically significant differences among groups 
were observed in psychological values, duration of 
symptoms (in months) (p˃0.05). No statistically signifi-
cant differences among groups were observed in pres-
ence of bruxism, malocclusion, edentulism, or previous 
history of trauma considered capable of affecting thera-
peutic outcomes (p˃0.05).
Neither lateral movement nor MMO varied significantly 
among the groups (p˃0.05), (Table 1). Similarly, de-
creases in VAS scores did not vary significantly among 
groups (p˃0.05), (Table 2).
Statistically significant differences in TMJ tenderness 
at palpation among groups were observed only at 1 
month postoperatively (p<0.05). No statistically sig-
nificant differences among groups were observed in the 






mean±SD    F value P value
Pre-
arthrocentesis 25.50±6.11 25.59±6.02 27.36±4.57 25.32±6.99
0.28 0.840
1st week 28.86±7.40 27.50±5.25 27.95±4.80 25.77±6.52 0.50 0.684
1 st month 31.82±7.37 30.09±4.99 30.50±4.78 30.55±8.20 0.15 0.932
3 rd month 32.73±5.75 33.19±5.30 33.09±5.82 30.90±6.53 0.36 0.781
6 th month 35.36±7.35 37.55±5.73 33.68±4.81 33.45±7.59 0.94 0.430








mean±SD F value P value
Pre-
arthrocentesis 8.00±2.00 7.09±2.98 8.45±1.92 7.45±2.62 0.68 0.571
1st week 5.00±3.66 5.45±2.91 5.18±3.71 5.00±3.97 0.04 0.989
1 st month 2.45±3.14 2.09±1.81 2.55±2.34 2.82±3.28 0.14 0.938
3 rd month 2.18±2.82 2.09±2.43 3.45±3.59 1.73±3.35 0.66 0.582
6 th month 1.55±2.77 0.55±0.69 2.00±2.61 1.73±2.97 0.74 0.531




   Group І
    n (%)
    Group ІІ
      n (%)
   Group ІІІ
     n (%)
   Group ІV
      n (%) P value
Pre-arthrocentesis 11(%100) 8(%72.7) 10(%90.9) 8(%72.7) 0.204
1 st week 6(%54.5) 5(%45.5) 5(%45.5) 6(%54.5) 0.947
1 st month 4(%36.4) 0(%0) 7(%63.6) 3(%27.3) 0.014*
3 rd month 2(%18.2) 2(%18.2) 2(%18.2) 3(%27.3) 0.936
6 th month 1(%9.1) 1(%9.1) 1(%9.1) 3(%27.3) 0.509
Table 3. Analysis of scores of TMJ tenderness at palpation.
*: P < 0.05.
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muscles of mastication regarding tenderness at palpa-
tion (Tables 3,4). Overall treatment success did not very 
significantly among the groups (Fig. 1).
- Radiological Findings 
No statistically significant differences were observed in 
the pre- or post-treatment presence of reduction, range 
of motion, joint space width, or effusion levels among 
the groups (p˃0.05). However, the differences between 
pre- and postoperative values were statistically signifi-
cant for all groups (Fig. 2).
Tenderness at 
palpation
   Group І
    n (%)
    Group ІІ
      n (%)
   Group ІІІ
     n (%)
   Group ІV
      n (%)         P value
Pre-arthrocentesis 7(%63.6) 9(%81.8) 11(%100) 7(%63.6) 0.127
1 st week 6(%54.5) 9(%81.8) 7(%63.6) 7(%63.6) 0.588
1 st month 3(%27.3) 7(%63.6) 8(%72.7) 3(%27.3) 0.056
3 rd month 3(%27.3) 6(%54.5) 6(%54.5) 4(%36.4) 0.475
6 th month 1(%9.1) 2(%18.2) 3(%27.3) 4(%36.4) 0.459
Table 4. Analysis of scores of muscles of mastication tenderness at palpation.
Fig. 1. Evaluation of the groups according to treatment success.
Fig. 2. a: The disc was located ante-
rior to the condyle prior to treatment. 
b: The disc was normal position after 
treatment. c:  Image of a joint effu-
sion prior to treatment. d: There was 
no effusion after treatment.
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Discussion 
There are two perspectives concerning the best form 
of treatment for patients with non-reducing disc dis-
placement. One involves starting with conservative 
treatment options to give the joint time to repair itself 
and adapt to derangement, and to progress to more ad-
vanced forms of treatment, such as arthrocentesis, only 
if no results have been obtained after a specific period 
of time (2). The other perspective calls for the immedi-
ate use of arthrocentesis or other simple, non-invasive 
technique without delay (19). Nitzan et al. (1) reported 
no treatment with physiotherapy before arthrocentesis 
to be unsuccessful, but found physiotherapy applied af-
ter arthrocentesis to increase treatment success further 
than physiotherapy alone. 
Lavage of the upper joint space during arthrocentesis 
may be performed using either Ringer’s lactate or saline 
solution; however, Ringer’s lactate solution has been 
reported to be better tolerated by the fibrous tissue of 
the articular disc (20). For this reason, the present study 
used Ringer’s lactate solution for arthrocentesis in all 
patients. There is no consensus regarding the amount 
of solution to be used in arthrocentesis (21), and studies 
have been conducted using anywhere between 50-500 
ml for TMJ lavage (3,22). Zardeneta et al. (22) reported 
that approximately 100 ml of solution was sufficient to 
remove specific proteins and proteases from the joint. 
The present study used 200 ml of Ringer’s Lactate solu-
tion for TMJ lavage.
Injections of a variety of drugs can be performed fol-
lowing TMJ arthrocentesis, with intra-articular steroids 
(1,8) and SH (5,6,23,24); reportedly the most common 
ones used following arthrocentesis performed for the 
treatment of non-reducing disc displacement. Intra-
articular tenoxicam was also used in one study (6), and 
there are other studies that have not used any drug in-
jection following arthrocentesis (19,25).
Sato et al. (23) reported a significant decrease in TMJ 
tenderness following SH injection after arthrocentesis 
in patients with non-reducing disc displacement, which 
the authors attributed to both the elimination of chemi-
cal mediators that cause pain and inflammation and SH’s 
ability to penetrate synovial tissue to prevent adhesion 
and reduce pain. Alpaslan and Alpaslan (5) reported de-
creases in pain and increases in MMO and lateral move-
ment following arthrocentesis, both with and without SH, 
when used to treat internal derangement of the TMJ. The 
authors also suggested that SH provided long-term vis-
cosity to joint surfaces and prevented the accumulation of 
pain-producing mediators. In a study of 28 patients with 
pain and internal derangement of the TMJ, Huddleston et 
al. (26) found decreases in pain and increases in MMO 
following arthrocentesis with or without a subsequent 
steroid injection, with the steroid administration having 
no significant effect on treatment outcomes.
There is no previous study comparing the effectiveness 
of SH and steroid injection following arthrocentesis in 
the treatment of non-reducing disc displacement; how-
ever a number of studies have compared the two alter-
natives in treating other TMJ diseases. Intra-articular 
steroid and SH injections were reported to be similarly 
effective in terms of increasing MMO and reducing 
pain in patients with TMJ internal derangement (27). 
Both drugs were also found to improve long-term clini-
cal symptoms in patients with chronic arthritis of the 
TMJ, although SH was recommended as a better alter-
native because it has fewer side effects (27).
Only two studies in the literature have reported on the 
use of tenoxicam in conjunction with arthrocentesis of 
the TMJ (6,7). In one of these studies, Aktas et al. (6). 
reported an increase in MMO and a decrease in pain 
after arthrocentesis followed by an intra-articular injec-
tion of tenoxicam used to treat TMJ non-reducing disc 
displacement. In the other study, Emes et al. (7) Found 
no differences in MMO increases or pain reduction in 
groups injected with tenoxicam vs SH intra-articularly 
for the treatment of TMJ internal derangement.
The main aim in using arthrocentesis to treat diseases 
such as non-reducing disc displacement is to reduce 
pain and increase function (28). Treatment success is 
dependent upon effective lysis and lavage of the supe-
rior joint space rather than on any ability of arthrocente-
sis to reduce displacement (25). Effective lavage results 
in the elimination of the vacuum in the superior joint 
space, an increase in the viscosity of synovial fluid, and 
facilitation of disc and condyle translation (1). Even if 
the disc is not reduced, an increase in MMO and de-
crease in pain are established with the adaptation and 
repair of the joint (21). Emshoff et al. (25) reported a 
decrease in pain and an increase in mandibular move-
ment with the application of arthrocentesis in patients 
with non-reducing disc displacement, but observed no 
change in disc position. Similarly, De Riu et al. (24) 
reported significant decreases in pain and increases in 
MMO in patients with internal derangement of the TMJ 
who received arthrocentesis followed by SH injection, 
but MRIs showed no change in disc position, disc mor-
phology or bone marrow edema. In the present study, al-
though disc reduction was observed in only 12 (27.2%) 
out of 44 cases, successful results were achieved in 28 
(64%) out of 44 cases. This success rate is within the 
range of 63%-95% reported for arthrocentesis (1,19,23). 
Giraddi et al. (8).  suggested that lavage of superior joint 
space exerts its effects via its ability to eliminate joint 
effusion. In our study, the amount of effusion decreased 
following arthrocentesis. 
Occlusal splint is an effectively therapy used for the 
treatment of disc displacement (29). It is suggested that 
splint therapy does not improve the disc position, but is 
strongly related to the basic decoupling of neuromus-
Med Oral Patol Oral Cir Bucal. 2018 May 1;23 (3):e351-8.                                                                                                                                     Disc displacement of the temporomandibular joint
e357
cular reflex mechanism and reduction of TMJ (30). Al-
though previous studies compared different splint de-
signs, there is no consensus on the selection of specific 
splint designs (29). Therefore, a relaxed masticatory 
musculature and stable physiological stress relation-
ships in joint structures were achieved (30). 
A limitation of the present study is patient population 
included that only patient with non-reducing disc dis-
placement of the TMJ. Another limitation of the study 
is patient monitoring was only six months after artro-
centesis. Additional research is required that included 
also patients with another TMJ diseases which may be 
treated with arthrocentesis and to evaluate the long-
term effects on the TMJ structures from arthrocentesis 
and intra-articular material injections. 
Conclusion
According to the data from this study, it may be con-
cluded that either arthrocentesis alone or arthrocentesis 
with methylprednisolone acetate or sodium hyaluronate 
or tenoxicam intra-articular injections are similarly ef-
fective and promising methods in the treatment of TMJ 
with non-reducing disc displacement. Considering that 
TMJ non-reducing disc displacement is a multifacto-
rial complex disease, comprehensive, long-term clinical 
studies with a larger sample size are needed to provide 
a definitive recommendation regarding the best method 
of treatment. 
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